Published online Jun 19, 2022. doi: 10.5498/wjp.v12.i6.787
Peer-review started: August 20, 2021
First decision: October 4, 2021
Revised: October 15, 2021
Accepted: May 5, 2022
Article in press: May 5, 2022
Published online: June 19, 2022
Processing time: 297 Days and 16.8 Hours
Many parents seek help from mental health experts due to irritability in children with attention-deficit/hyperactivity disorder (ADHD). But treatment efficacy for irritable and aggressive ADHD in children remains ineffective. Therefore, the heterogeneity to ADHD treatment should be proposed by a specific mathematical method.
Treating children with ADHD is not only a matter of treating inattentive symptoms alone. It is important to understand the factors that influence treatment outcomes for those with ADHD.
This study used the generalized structural equation modeling (GSEM) pathway analysis to analyze heterogeneity in ADHD.
We used the GSEM to test the hypothesis that ODD is essentially an intermediate mediator of treatment effectiveness for ADHD (in terms of odds of reaching remission or the chance of remission) by direct and indirect pathway analysis.
Higher irritable oppositional defiant disorder (ODD) symptom levels mediated the treatment outcomes in children with ADHD. Earlier recognition of risky hyperactivity/impulsivity ADHD symptoms + irritable ODD + childhood aggression as a particular subgroup and earlier provision of a more intensive combination of pharmacotherapy and cognitive behavior therapy modalities are essential.
Treating children with ADHD is not only a matter of treating inattentive symptoms alone, but there is also a need to recognize and manage symptoms of ODD and the presented aggressive behavior, delinquent behavior, and thought problems in children with ADHD to improve ADHD treatment outcomes.
Poor treatment outcomes in ADHD can be predicted as irritable ODD subtype of ADHD with aggressive behavior. An early and more intensive combined biopsychosocial model approach for ADHD should be warranted for these children. This study revealed additional insights into devising more efficacious pharmacotherapies and cognitive behavior therapies.
